IPO Trending
ONYXSME / NSEListed
Onyx Biotec

Incorporated in May 2005, Onyx Biotec Limited is a pharmaceutical company focused on producing sterile water for injections and offering contract manufacturing services. It operates two facilities in Solan, Himachal Pradesh, where Unit I makes up to 6.38 lakh units of sterile water injections daily, and Unit II manufactures 40,000 units of dry powder injections and 26,667 units of dry syrup per day. The company caters to both domestic and international markets and serves over 100 clients, including well-known names like Hetero Healthcare, Mankind Pharma, Sun Pharma, and Reliance Life Sciences. Onyx Biotec is ISO 9001:2015 and ISO 14001:2015 certified and employed 175 people as of July 31, 2024.

₹58 - ₹61198.68x sub
Listed Price₹54.05
Listing Gain-11.39%

Subscription Status

198.68xTotal Demand
Updated 20 Oct 2026, 01:30 AM
QIB32.49x
🔥 Blockbuster Sizzling Demand!Offered: 9,12,000 sh
Nib603.44x
🔥 Blockbuster Sizzling Demand!Offered: 6,88,000 sh
Retail119.36x
🔥 Blockbuster Sizzling Demand!Offered: 16,00,000 sh
CategoryOfferedAppliedTimes
QIB9,12,0002,96,34,00032.49x
Nib6,88,00041,51,66,000603.44x
Retail16,00,00019,09,78,000119.36x

Segment Subscription Demand

Segment / CategoryDemand (Shares)Offered (Shares)Times Sub.
QIB180.775.5632.51x
Retail1,164.979.76119.36x
Hnis 2+00Open
Hnis 10+00Open
Employees00Open
Shareholder00Open

Application-wise Breakup

CategoryReservedAppliedTimes Sub.
QIB022Open
Nib09,351Open
Retail095,489Open
Bidding status cross-verified with live IPO subscription numbers ↗BSE & NSE Bidding Portal Feed

About Onyx Biotec IPO Subscription Demand

Live subscription status and bidding analysis for Onyx Biotec (ONYX) IPO. The issue is subscribed 198.68x overall across Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII/HNI), and Retail Individual Investors (RII). Check real-time grey market demand on our GMP Tracker or review full issue details, lot size, and price band on the IPO Details Page.

Frequently Asked Questions